ABOUT THIS BOOK
Despite rapid advances in understanding the biology of ovarian cancer, progress
in treatment has been slow. But the prospects for improvement have never been
better. A wide range of novel therapeutic targets now present themselves for
clinical evaluation and initial results are certainly encouraging. In this text,
all these areas are covered by experts in the field. Each chapter provides up-to-date
coverage of clinical information, prefaced by a description of the rational
basis for the selection of each target area and consideration of biomarkers
that can be used to aid clinical evaluation. The four editors work together
within the Ovarian Cancer Action collaborative research programme in London
and they bring a wealth of laboratory and clinical expertise to this topic.
The text should provide an invaluable source of reference for clinical and laboratory-based
researchers working to meet the challenges of ovarian cancer.
Content Level » Research
Related subjects » Cancer Research - Pharmaceutical Science